Lack of association of metastasis-associated lung adenocarcinoma transcript 1 variants with melanoma skin cancer risk

Elisa Orlandi, Chiara Zanot, Albino Poli, Morena Nicolis, Monica Rodolfo, Alberto Turco, Antonella Sangalli, Macarena Gomez-Lira

Research output: Contribution to journalArticle

Abstract

The long noncoding RNA (lncRNA) metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) has been implicated in melanoma. Polymorphisms in MALAT1 may play a vital role in the progress of melanoma by its regulative function. However, potential genetic variants in MALAT1 affecting the risk of melanoma onset have not been explored. In this study, two single nucleotide polymorphisms (rs3200401 and rs619586) in MALAT1 were selected for genotyping of 334 melanoma patients and 291 cancer-free controls in an Italian population. The results showed that MALAT1 rs3200401 and rs619586 were not associated with melanoma risk. A further breakdown analysis by sex stratification also indicated a lack of association between these polymorphisms and melanoma. In addition, we tested 450 bp of the proximal 5´ flanking region of the gene for the presence of polymorphisms that could be associated with melanoma risk and found no variants in 96 melanoma patients. In conclusion, our results suggest that there is no contribution of MALAT1 rs3200401 and rs619586 polymorphisms or polymorphisms in the core promoter that could be associated with the risk of melanoma skin cancer in this specific study setting. Further validation will be required in larger studies involving different settings/larger populations in order to reach conclusive results.

Original languageEnglish
Pages (from-to)660-663
Number of pages4
JournalMelanoma Research
Volume29
Issue number6
DOIs
Publication statusPublished - Dec 1 2019

Fingerprint

Skin Neoplasms
Melanoma
Neoplasm Metastasis
Long Noncoding RNA
Adenocarcinoma of lung
5' Flanking Region
Population
Single Nucleotide Polymorphism

ASJC Scopus subject areas

  • Oncology
  • Dermatology
  • Cancer Research

Cite this

Lack of association of metastasis-associated lung adenocarcinoma transcript 1 variants with melanoma skin cancer risk. / Orlandi, Elisa; Zanot, Chiara; Poli, Albino; Nicolis, Morena; Rodolfo, Monica; Turco, Alberto; Sangalli, Antonella; Gomez-Lira, Macarena.

In: Melanoma Research, Vol. 29, No. 6, 01.12.2019, p. 660-663.

Research output: Contribution to journalArticle

Orlandi, Elisa ; Zanot, Chiara ; Poli, Albino ; Nicolis, Morena ; Rodolfo, Monica ; Turco, Alberto ; Sangalli, Antonella ; Gomez-Lira, Macarena. / Lack of association of metastasis-associated lung adenocarcinoma transcript 1 variants with melanoma skin cancer risk. In: Melanoma Research. 2019 ; Vol. 29, No. 6. pp. 660-663.
@article{a1d315eb29094fdb8761ae00c17b1d9e,
title = "Lack of association of metastasis-associated lung adenocarcinoma transcript 1 variants with melanoma skin cancer risk",
abstract = "The long noncoding RNA (lncRNA) metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) has been implicated in melanoma. Polymorphisms in MALAT1 may play a vital role in the progress of melanoma by its regulative function. However, potential genetic variants in MALAT1 affecting the risk of melanoma onset have not been explored. In this study, two single nucleotide polymorphisms (rs3200401 and rs619586) in MALAT1 were selected for genotyping of 334 melanoma patients and 291 cancer-free controls in an Italian population. The results showed that MALAT1 rs3200401 and rs619586 were not associated with melanoma risk. A further breakdown analysis by sex stratification also indicated a lack of association between these polymorphisms and melanoma. In addition, we tested 450 bp of the proximal 5´ flanking region of the gene for the presence of polymorphisms that could be associated with melanoma risk and found no variants in 96 melanoma patients. In conclusion, our results suggest that there is no contribution of MALAT1 rs3200401 and rs619586 polymorphisms or polymorphisms in the core promoter that could be associated with the risk of melanoma skin cancer in this specific study setting. Further validation will be required in larger studies involving different settings/larger populations in order to reach conclusive results.",
author = "Elisa Orlandi and Chiara Zanot and Albino Poli and Morena Nicolis and Monica Rodolfo and Alberto Turco and Antonella Sangalli and Macarena Gomez-Lira",
year = "2019",
month = "12",
day = "1",
doi = "10.1097/CMR.0000000000000605",
language = "English",
volume = "29",
pages = "660--663",
journal = "Melanoma Research",
issn = "0960-8931",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Lack of association of metastasis-associated lung adenocarcinoma transcript 1 variants with melanoma skin cancer risk

AU - Orlandi, Elisa

AU - Zanot, Chiara

AU - Poli, Albino

AU - Nicolis, Morena

AU - Rodolfo, Monica

AU - Turco, Alberto

AU - Sangalli, Antonella

AU - Gomez-Lira, Macarena

PY - 2019/12/1

Y1 - 2019/12/1

N2 - The long noncoding RNA (lncRNA) metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) has been implicated in melanoma. Polymorphisms in MALAT1 may play a vital role in the progress of melanoma by its regulative function. However, potential genetic variants in MALAT1 affecting the risk of melanoma onset have not been explored. In this study, two single nucleotide polymorphisms (rs3200401 and rs619586) in MALAT1 were selected for genotyping of 334 melanoma patients and 291 cancer-free controls in an Italian population. The results showed that MALAT1 rs3200401 and rs619586 were not associated with melanoma risk. A further breakdown analysis by sex stratification also indicated a lack of association between these polymorphisms and melanoma. In addition, we tested 450 bp of the proximal 5´ flanking region of the gene for the presence of polymorphisms that could be associated with melanoma risk and found no variants in 96 melanoma patients. In conclusion, our results suggest that there is no contribution of MALAT1 rs3200401 and rs619586 polymorphisms or polymorphisms in the core promoter that could be associated with the risk of melanoma skin cancer in this specific study setting. Further validation will be required in larger studies involving different settings/larger populations in order to reach conclusive results.

AB - The long noncoding RNA (lncRNA) metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) has been implicated in melanoma. Polymorphisms in MALAT1 may play a vital role in the progress of melanoma by its regulative function. However, potential genetic variants in MALAT1 affecting the risk of melanoma onset have not been explored. In this study, two single nucleotide polymorphisms (rs3200401 and rs619586) in MALAT1 were selected for genotyping of 334 melanoma patients and 291 cancer-free controls in an Italian population. The results showed that MALAT1 rs3200401 and rs619586 were not associated with melanoma risk. A further breakdown analysis by sex stratification also indicated a lack of association between these polymorphisms and melanoma. In addition, we tested 450 bp of the proximal 5´ flanking region of the gene for the presence of polymorphisms that could be associated with melanoma risk and found no variants in 96 melanoma patients. In conclusion, our results suggest that there is no contribution of MALAT1 rs3200401 and rs619586 polymorphisms or polymorphisms in the core promoter that could be associated with the risk of melanoma skin cancer in this specific study setting. Further validation will be required in larger studies involving different settings/larger populations in order to reach conclusive results.

UR - http://www.scopus.com/inward/record.url?scp=85074552638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074552638&partnerID=8YFLogxK

U2 - 10.1097/CMR.0000000000000605

DO - 10.1097/CMR.0000000000000605

M3 - Article

C2 - 30870271

AN - SCOPUS:85074552638

VL - 29

SP - 660

EP - 663

JO - Melanoma Research

JF - Melanoma Research

SN - 0960-8931

IS - 6

ER -